Does ADALIMUMAB Cause Interstitial lung disease? 1,250 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 1,250 reports of Interstitial lung disease have been filed in association with ADALIMUMAB (YUSIMRY). This represents 0.3% of all adverse event reports for ADALIMUMAB.
1,250
Reports of Interstitial lung disease with ADALIMUMAB
0.3%
of all ADALIMUMAB reports
153
Deaths
471
Hospitalizations
How Dangerous Is Interstitial lung disease From ADALIMUMAB?
Of the 1,250 reports, 153 (12.2%) resulted in death, 471 (37.7%) required hospitalization, and 149 (11.9%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
Yes, Interstitial lung disease is listed as a known adverse reaction in the official FDA drug label for ADALIMUMAB.
What Other Side Effects Does ADALIMUMAB Cause?
Drug ineffective (71,926)
Pain (37,514)
Arthralgia (35,592)
Rheumatoid arthritis (29,817)
Fatigue (29,420)
Injection site pain (28,679)
Headache (19,891)
Nausea (19,299)
Rash (18,690)
Pain in extremity (18,319)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
TOCILIZUMAB (1,229)
Which ADALIMUMAB Alternatives Have Lower Interstitial lung disease Risk?
ADALIMUMAB vs ADALIMUMAB-AACF
ADALIMUMAB vs ADALIMUMAB-AATY
ADALIMUMAB vs ADALIMUMAB-ADAZ
ADALIMUMAB vs ADALIMUMAB-ADBM
ADALIMUMAB vs ADALIMUMAB-AFZB